Literature DB >> 23943088

Simultaneous optimal experimental design for in vitro binding parameter estimation.

C Steven Ernest1, Mats O Karlsson, Andrew C Hooker.   

Abstract

Simultaneous optimization of in vitro ligand binding studies using an optimal design software package that can incorporate multiple design variables through non-linear mixed effect models and provide a general optimized design regardless of the binding site capacity and relative binding rates for a two binding system. Experimental design optimization was employed with D- and ED-optimality using PopED 2.8 including commonly encountered factors during experimentation (residual error, between experiment variability and non-specific binding) for in vitro ligand binding experiments: association, dissociation, equilibrium and non-specific binding experiments. Moreover, a method for optimizing several design parameters (ligand concentrations, measurement times and total number of samples) was examined. With changes in relative binding site density and relative binding rates, different measurement times and ligand concentrations were needed to provide precise estimation of binding parameters. However, using optimized design variables, significant reductions in number of samples provided as good or better precision of the parameter estimates compared to the original extensive sampling design. Employing ED-optimality led to a general experimental design regardless of the relative binding site density and relative binding rates. Precision of the parameter estimates were as good as the extensive sampling design for most parameters and better for the poorly estimated parameters. Optimized designs for in vitro ligand binding studies provided robust parameter estimation while allowing more efficient and cost effective experimentation by reducing the measurement times and separate ligand concentrations required and in some cases, the total number of samples.

Mesh:

Substances:

Year:  2013        PMID: 23943088     DOI: 10.1007/s10928-013-9330-4

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  21 in total

1.  Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.

Authors:  S Retout; S Duffull; F Mentré
Journal:  Comput Methods Programs Biomed       Date:  2001-05       Impact factor: 5.428

2.  Optimal sampling time selection for parameter estimation in dynamic pathway modeling.

Authors:  Zoltán Kutalik; Kwang-Hyun Cho; Olaf Wolkenhauer
Journal:  Biosystems       Date:  2004-07       Impact factor: 1.973

3.  POPED, a software for optimal experiment design in population kinetics.

Authors:  Marco Foracchia; Andrew Hooker; Paolo Vicini; Alfredo Ruggeri
Journal:  Comput Methods Programs Biomed       Date:  2004-04       Impact factor: 5.428

4.  Derivation of various NONMEM estimation methods.

Authors:  Yaning Wang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-07-10       Impact factor: 2.745

5.  Methodological comparison of in vitro binding parameter estimation: sequential vs. simultaneous non-linear regression.

Authors:  C Steven Ernest; Andrew C Hooker; Mats O Karlsson
Journal:  Pharm Res       Date:  2010-03-11       Impact factor: 4.200

6.  Kinetic identification of a two-state glucagon receptor system in isolated hepatocytes. Interconversion of homogeneous receptors.

Authors:  E M Horwitz; W T Jenkins; N M Hoosein; R S Gurd
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

7.  DESIGN: computerized optimization of experimental design for estimating Kd and Bmax in ligand binding experiments. II. Simultaneous analysis of homologous and heterologous competition curves and analysis blocking and of "multiligand" dose-response surfaces.

Authors:  G E Rovati; D Rodbard; P J Munson
Journal:  Anal Biochem       Date:  1990-01       Impact factor: 3.365

8.  DESIGN: computerized optimization of experimental design for estimating Kd and Bmax in ligand binding experiments. I. Homologous and heterologous binding to one or two classes of sites.

Authors:  G E Rovati; D Rodbard; P J Munson
Journal:  Anal Biochem       Date:  1988-11-01       Impact factor: 3.365

9.  The importance of modeling interoccasion variability in population pharmacokinetic analyses.

Authors:  M O Karlsson; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1993-12

10.  Optimal experimental design for parameter estimation of a cell signaling model.

Authors:  Samuel Bandara; Johannes P Schlöder; Roland Eils; Hans Georg Bock; Tobias Meyer
Journal:  PLoS Comput Biol       Date:  2009-11-06       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.